Quest Diagnostics Reports First Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Mizuho Securities Raises Price Target on Quest Diagnostics (DGX) Following In-Line 1Q Results
April 21, 2016 2:16 PM EDTMizuho Securities reiterated an Outperform rating on Quest Diagnostics (NYSE: DGX), and raised the price target to $84.00 (from $75.00), following the company's 1Q earnings report. DGX reported an adjusted EPS of $1.12, in-line with consensus estimates.
Analyst Ann Hynes commented, "We are raising our price... More
Quest Diagnostics (DGX) Reports In-Line Q1 EPS; Reaffirms Outlook
April 21, 2016 6:47 AM EDTQuest Diagnostics (NYSE: DGX) reported Q1 EPS of $1.12, in-line with the analyst estimate of $1.12. Revenue for the quarter came in at $1.86 billion versus the consensus estimate of $1.82 billion.
"We're off to a good start in 2016 with a solid performance in the first... More
